FDA Orange Book · active-ingredient family
Calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride
Calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER · NDA 018460
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER×3 | B BRAUN | NDA 018460 | — | Jan 29, 1986 | |
| DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER×4 | B BRAUN | NDA 018807 | — | Aug 26, 1983 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
